CClinicalTrials.gg
CompletedNCT01492816Updated Feb 28, 2017

Enhancement of Connect to Protect® (C2P)

An interventional study of Community Mobilization in HIV Infection, sponsored by University of North Carolina, Chapel Hill. Completed at 9 sites in United States. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2017-02-28.

Sponsored by University of North Carolina, Chapel Hill · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
927
Allocation
Not applicable
Ages
16 Years and older
Sex
All
01

Study summary

The proposed study seeks to continue Connect to Protect® (C2P) community mobilization efforts that have developed coalitions that plan for and bring about structural changes for purposes of reducing HIV incidence and prevalence among youth in targeted communities at nine sites.

Read the detailed description

Earlier phases of C2P have been outlined in ATN Protocols 016a, 016b, 040/040b. The C2P community mobilization model entails: determining a geographic area and population of focus for the coalitions to prioritize their planning and action (accomplished in an earlier phase of C2P); coalitions establishing a shared vision and mission; development of a strategic plan focused on structural changes to reduce risks associated with HIV; process documentation; and feedback as technical assistance to the coalitions. The National Coordinating Center (NCC), operating under the direction of the Protocol Chair, provides guidance, training, technical assistance and feedback to coalitions.

This protocol continues the C2P mobilization effort and includes enhanced strategic planning activities to assist the coalitions in identifying necessary and relevant structural changes. The evaluation of C2P includes both process evaluation (i.e., documentation of coalition actions and achievements of structural changes; and outcome evaluation to qualitatively assess (via Key Informant (KI) interviews) if and how C2P efforts, including completed structural changes, have influenced the risk environment within each community. In addition, local health surveillance data and HIV testing data will be used to evaluate changes in HIV testing patterns and HIV/Sexually Transmitted Infection (STI) morbidity among youth.

02

Conditions studied

  • HIV Infection

Browse trials for

Keywords

  • HIV prevention
  • HIV positive communities
03

In context

HIV Infections

4,258 studies on the registry are indexed under HIV Infections; 240 are open to participants now.

This study's enrollment of 927 is above the median of 83 across 3,251 interventional studies indexed under HIV Infections.

Browse HIV Infections studies →

Lead sponsor

University of North Carolina, Chapel Hill is the lead sponsor of 1,340 studies on the registry; 133 are open to participants now.

Of its 155 completed or terminated interventional studies of FDA-regulated products, 136 (88%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  1. The intervention group = Community members who become engaged in the coalitions and in the broader mobilization effort; and
  2. The evaluation group = Key Informants within each C2P community who either work or reside within the sectors or systems where structural changes have been accomplished and/or the coalition has focused their strategic planning efforts.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
927 participants (actual)

Study arms

  • Experimental
    Intervention Group

    Community members who become engaged in the coalitions and in the broader mobilization effort. A subset of community members.

    Behavioral: Community Mobilization

Interventions

  • BehavioralCommunity Mobilization

    The proposed study seeks to continue C2P community mobilization efforts that have developed coalitions that plan for and bring about structural changes for purposes of reducing Human Immunodeficiency Virus (HIV) incidence and prevalence among youth in targeted communities at nine sites. Earlier phases of C2P have been outlined in ATN Protocols 016a, 016b, 040/040b. The C2P community mobilization model entails: determining a geographic area and population of focus for the coalitions to prioritize their planning and action (accomplished in an earlier phase of C2P); coalitions establishing a shared vision and mission; development of a strategic plan focused on structural changes to reduce risks associated with HIV; process documentation; and feedback as technical assistance to the coalitions.

06

What researchers measure

Primary outcomes

  1. To assess the extent to which C2P activities influence elements of the community that affect HIV-related risk prevention, testing, treatment and linkage to healthcare among youth aged 12-24 years and represent intermediate outcomes for this study.

    Assessment will include evaluation across three primary intermediate outcome areas: 1. Achievement of SCOs (programs, policies, practices) that target increased levels of HIV-related prevention, testing, and linkage to healthcare. 2. Increased community capacity and social capital to address HIV-related prevention, testing, and linkage to healthcare. 3. Increasing levels of sustainability across the HIV continuum of care (CoC) including prevention, testing, and linkage to healthcare activities initiated or influenced by C2P, including programs, policies, and new relationships between people or organizations.

    Time frame: End of year 5 (study completion)

Secondary outcomes

  1. Examine how attributes of the SCOs relate to intermediate outcomes in order to provide guidance and recommendations to policy makers.

    Attributes that will be analyzed include: 1. Change strategy (e.g., information provision, policy change, relationship formation, program creation). 2. Sector(s) where change occurs. 3. Distal vs. proximal causes targeted. 4. Youth population affected by change (e.g., universal, selected or indicated). In addition, strategies associated with SCO achievement (e.g., creating linkages, honest brokering, strategic partnering, etc.) will be examined for trends and associations.

    Time frame: End of year 5 (study completion)

  2. Assess the trends and associations with strategies used to achieve SCOs (e.g., creating linkages, honest brokering, strategic partnering, etc.)

    Time frame: End of year 5 (study completion)

07

Study locations

9 sites
  • Children's Hospital of Los Angeles
    Los Angeles, California 90054, United States
  • Children's Hosp Natinal Med Center
    Washington, District of Columbia 20010, United States
  • University of Miami School of Medicine
    Miami, Florida 33101, United States
  • University of South Florida
    Tampa, Florida 33606, United States
  • Stoger Hospital of Cook County
    Chicago, Illinois 60612, United States
  • Tulane University Health Sciences Center
    New Orleans, Louisiana 70112, United States
  • Montefiore Medical Center
    Bronx, New York 10467, United States
  • Children's Hospital of Philadelphia
    Philadelphia, Pennsylvania 19104, United States
  • St. Jude Childrens Research Hospital
    Memphis, Tennessee 38105, United States
08

References and documents

Related links

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 28, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01492816
Lead sponsor
University of North Carolina, Chapel Hill
Collaborators
National Institute on Drug Abuse (NIDA), National Institute of Mental Health (NIMH)
Responsible party
Sponsor
First posted
Dec 15, 2011
Start date
Aug 2011
Primary completion
Apr 2016
Completion
May 2016
Last update
Feb 28, 2017

Study contacts

Jonathan Ellen, MD
study chair · Johns Hopkins University Hospital

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion